Loading…
In person · Pittsburgh · PA · United States
Research provider: Pitt+Me
Are you less than 36 weeks pregnant? You may be eligible for a research study looking at an investigational maternal vaccine that is designed to protect pregnant women and their babies from the 6 most common types of Group B streptococcus (GBS). If you join this study, you will receive 1 dose of the study vaccine or placebo between weeks 24 and 36 of your pregnancy. Compensation is provided.
If you join this study, you will receive 1 dose of the study vaccine or placebo between weeks 24 and 36 of your pregnancy. A placebo looks like the study vaccine but has no active ingredients. You will be in the study until about 6 months after your baby is born and will have at least 5-6 study visits. Your baby will be in the study until they are 12 months old and will have at least 4 study visits. Some of these visits may occur by phone. You may also be invited to enroll your baby in an optional phase of the study where they would receive other childhood vaccines and have additional study visits.
Are you less than 36 weeks pregnant? You may be eligible for a research study looking at an investigational maternal vaccine that is designed to protect pregnant women and their babies from the 6 most common types of Group B streptococcus (GBS). If you join this study, you will receive 1 dose of the study vaccine or placebo between weeks 24 and 36 of your pregnancy. Compensation is provided.
Review the provider’s screening questions. These requirements do not guarantee selection.